GlassScriptPhysician profile
Harit Desai
NPI 1548472905
$7,646.13
in general payments reported to CMS, 2019-2025
26 companies · $2,872 in 2025
The $2,872 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $114 · 2021: $532 · 2022: $1,121 · 2023: $666 · 2024: $1,783 · 2025: $2,872.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,062 · Travel and Lodging: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,062.02 |
| Travel and Lodging | $1,258.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,966.93 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Edwards Lifesciences Corporation | $1,771.25 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal |
| Boston Scientific Corporation | $585.28 | 2019-2025 | Avvigo Guidance System |
| Abbott Laboratories | $533.78 | 2019-2025 | Mitraclip, Xience Sierra, Aveir |
| Shockwave Medical, INC | $314.21 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $240.05 | 2021-2025 | |
| Medtronic Vascular, INC. | $207.39 | 2019-2020 | |
| Inari Medical, INC. | $143.53 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.65 | 2019-2023 | Lifevest |
| Janssen Pharmaceuticals, INC | $118.56 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $75.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $70.00 | 2019-2023 | Farxiga |
| Pfizer INC. | $64.61 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $56.92 | 2022-2025 | Camzyos |
| Avinger INC. | $55.54 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $46.99 | 2025 | Mcot, Extended Holter |
| Amgen INC. | $46.58 | 2022-2024 | Repatha |
| Cardiovascular Systems INC. | $37.26 | 2019-2020 | |
| Novo Nordisk INC | $36.09 | 2022 | |
| Preventice Services, LLC | $30.47 | 2021 | |
| Cardiva Medical, INC. | $26.51 | 2024 | Savvywire |
| Sanofi-Aventis U.S. LLC | $24.54 | 2019 | |
| Recor Medical INC | $24.21 | 2024 | Paradise Renal Denervation System |
| W. L. Gore & Associates, INC. | $19.32 | 2021 | |
| Ambu INC. | $17.13 | 2025 | |
| Chiesi USA, INC. | $14.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harit Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.